@article{fc27bf9b82924070b6bc32458d77d09d,
title = "Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United Sates, 2000-2013",
abstract = "Background. Rotavirus is a common cause of acute gastroenteritis and has also been associated with generalized tonic-clonic afebrile seizures. Since rotavirus vaccine introduction, hospitalizations for treatment of acute gastroenteritis have decreased. We assess whether there has been an associated decrease in seizure-associated hospitalizations. Methods. We used discharge codes to abstract data on seizure hospitalizations among children <5 years old from the State Inpatient Databases of the Healthcare Cost and Utilization Project. We compared seizure hospitalization rates before and after vaccine introduction, using Poisson regression, stratifying by age and by month and year of admission. We performed a time-series analysis with negative binomial models, constructed using prevaccine data from 2000 to 2006 and controlling for admission month and year. Results. We examined 962 899 seizure hospitalizations among children <5 years old during 2000-2013. Seizure rates after vaccine introduction were lower than those before vaccine introduction by 1%-8%, and rate ratios decreased over time. Time-series analyses demonstrated a decrease in the number of seizure-coded hospitalizations in 2012 and 2013, with notable decreases in children 12-17 months and 18-23 months. Conclusions. Our analysis provides evidence for a decrease in seizure hospitalizations following rotavirus vaccine introduction in the United States, with the greatest impact in age groups with a high rotavirus-associated disease burden and during rotavirus infection season.",
keywords = "Rotavirus, Seizures, Vaccine",
author = "Pringle, {Kimberly D.} and Burke, {Rachel M.} and Steiner, {Claudia A.} and Parashar, {Umesh D.} and Tate, {Jacqueline E.}",
note = "Funding Information: 1Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, and 2Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia; and 3Healthcare Cost and Utilization Project, Center for Delivery, Organization, and Markets, Agency for Healthcare Research and Quality, Rockville, Maryland aPresent affiliation: Institute for Health Research, Kaiser Permanente Colorado, Denver. Funding Information: Acknowledgments. We thank the following HCUP state partners for their active support of this evaluation: the Arizona Department of Health Services, the California Office of Statewide Health Planning and Development, the Colorado Hospital Association, the Connecticut Hospital Association, the Florida Agency for Health Care Administration, the Georgia Hospital Association, the Hawaii Health Information Corporation, the Illinois Department of Public Health, the Iowa Hospital Association, the Kansas Hospital Association, the Kentucky Cabinet for Health and Family Services, the Maryland Health Services Cost Review Commission, the Massachusetts Center for Health Information and Analysis, the Michigan Health and Hospital Association, the Missouri Hospital Industry Data Institute, the New Jersey Department of Health, the New York State Department of Health, the North Carolina Department of Health and Human Services, the Oregon Association of Hospitals and Health Systems, the South Carolina Revenue and Fiscal Affairs Office, the Tennessee Hospital Association, the Texas Department of State Health Services, the Utah Department of Health, the Washington State Department of Health, the West Virginia Health Care Authority, and the Wisconsin Department of Health Services. Publisher Copyright: {\textcopyright} The Author(s) 2017.",
year = "2018",
month = feb,
day = "15",
doi = "10.1093/infdis/jix589",
language = "English (US)",
volume = "217",
pages = "581--588",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "4",
}